Necrotising Enterocolitis
10
2
2
5
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
0.0%
0 terminated out of 10 trials
100.0%
+13.5% vs benchmark
20%
2 trials in Phase 3/4
20%
1 of 5 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 5 completed trials
Clinical Trials (10)
Health-Related Quality-of-Life and Household Financial and Wellbeing Impacts of Prematurity and Necrotising Enterocolitis (NEC).
Markers of Platelet Activation foR Identification of Late Onset Sepsis in Preterm Infants
The Intestinal Innate Immune System in Newborns. Development and Inflammation in Health and Disease
Characterization of Intestinal Microbiota Stability in Preterm Born Neonates
Enteral Feeding in Infants With Duct Dependant Lesions.
Predictors of Neonatal Necrotizing Enterocolitis
Imaging Modalities in Diagnosing Necrotizing Enterocolitis in Preterm Infants.
Lactoferrin Prophylaxis in VLBW and Regulator T-cells
The Efficacy of Symbiotic on Cytokines
Withholding Feeds During Red Blood Cell Transfusion and TRAGI